This presser was about how trump was “lowering the price” of weight loss meds. He’s not lowering shit! They are getting their asses kicked by compounders and are lowering the price to hold the market. This was a toss to trump to show he’s here for us. Fuck him and fuck the fainty guy.
holy shit -- one of Trump's toadies just passed out and the White House event is brought to an abrupt end
November 6, 2025 at 6:12 PM
This presser was about how trump was “lowering the price” of weight loss meds. He’s not lowering shit! They are getting their asses kicked by compounders and are lowering the price to hold the market. This was a toss to trump to show he’s here for us. Fuck him and fuck the fainty guy.
Small caps on the verge of a multi-year breakout.
We searched for $IWM stocks most likely to double free cash flow in two years.
$FOUR $ROAD $PRDO $GPI all quiet compounders ready to run. 💸
We searched for $IWM stocks most likely to double free cash flow in two years.
$FOUR $ROAD $PRDO $GPI all quiet compounders ready to run. 💸
October 23, 2025 at 1:30 AM
Small caps on the verge of a multi-year breakout.
We searched for $IWM stocks most likely to double free cash flow in two years.
$FOUR $ROAD $PRDO $GPI all quiet compounders ready to run. 💸
We searched for $IWM stocks most likely to double free cash flow in two years.
$FOUR $ROAD $PRDO $GPI all quiet compounders ready to run. 💸
oh you'll give a shit
the one thing I didn't count on is how much of our investment gains have just been buy-and-hold compounders that would've been (in retrospect) better off in a taxable account that we only pay cap gains on, vs treated as income
the one thing I didn't count on is how much of our investment gains have just been buy-and-hold compounders that would've been (in retrospect) better off in a taxable account that we only pay cap gains on, vs treated as income
September 23, 2025 at 2:15 PM
oh you'll give a shit
the one thing I didn't count on is how much of our investment gains have just been buy-and-hold compounders that would've been (in retrospect) better off in a taxable account that we only pay cap gains on, vs treated as income
the one thing I didn't count on is how much of our investment gains have just been buy-and-hold compounders that would've been (in retrospect) better off in a taxable account that we only pay cap gains on, vs treated as income
[Motley Fool]3 Hot Artificial Intelligence (AI) Stocks to Buy With $1,000 and Hold Forever - Yahoo Finance These three compounders can turn $1,000 into significant wealth over a lifetime.
March 26, 2024 at 1:30 AM
[Motley Fool]3 Hot Artificial Intelligence (AI) Stocks to Buy With $1,000 and Hold Forever - Yahoo Finance These three compounders can turn $1,000 into significant wealth over a lifetime.
Three ways to identify capital compounders: If companies that are long-term compounders of value are the holy grail of investing, what kind of attributes should advisors and investors look for?
Three ways to identify capital compounders
If companies that are long-term compounders of value are the holy grail of investing, what kind of attributes should advisors and investors look for?
www.theglobeandmail.com
July 9, 2024 at 8:49 AM
Three ways to identify capital compounders: If companies that are long-term compounders of value are the holy grail of investing, what kind of attributes should advisors and investors look for?
Dividend Compounders with Cheese on YouTube had a great video explaining his thoughts on $FLO! What are your thoughts on this baking powerhouse?
stockbossup.com/pages/post/3...
stockbossup.com/pages/post/3...
Flowers Foods: A Dividend Powerhouse Often Overlooked
Flowers Foods is a name that rarely gets mentioned when discussing high-performing dividend stocks. Yet, the company's all-time total return since its IPO is a staggering 40,000%!
stockbossup.com
April 15, 2025 at 11:11 PM
Dividend Compounders with Cheese on YouTube had a great video explaining his thoughts on $FLO! What are your thoughts on this baking powerhouse?
stockbossup.com/pages/post/3...
stockbossup.com/pages/post/3...
Det sägs att den som väntar på något gott väntar aldrig för länge...och nu är boken "The Compounders" äntligen här!
Boken är till för investerare, företagsledare eller alla aktieintresserade som vill veta vad som krävs att nå stark långsiktig avkastning.
req.no/thecompounders
Boken är till för investerare, företagsledare eller alla aktieintresserade som vill veta vad som krävs att nå stark långsiktig avkastning.
req.no/thecompounders
September 2, 2025 at 6:42 AM
Det sägs att den som väntar på något gott väntar aldrig för länge...och nu är boken "The Compounders" äntligen här!
Boken är till för investerare, företagsledare eller alla aktieintresserade som vill veta vad som krävs att nå stark långsiktig avkastning.
req.no/thecompounders
Boken är till för investerare, företagsledare eller alla aktieintresserade som vill veta vad som krävs att nå stark långsiktig avkastning.
req.no/thecompounders
Der tales i Børsens podcast om, at Novo Nordisk har en øget risiko ved, at semaglutid ryger af patent i 2031 i USA.
Sådan ser jeg det ikke. Patentet er allerede delvist værdiløst, da der er tæt på nulvækst og "compounders" servicerer hele markedet i USA. En dyr lektie, men bunden er nået.
#dkøko
Sådan ser jeg det ikke. Patentet er allerede delvist værdiløst, da der er tæt på nulvækst og "compounders" servicerer hele markedet i USA. En dyr lektie, men bunden er nået.
#dkøko
November 6, 2025 at 6:13 AM
Der tales i Børsens podcast om, at Novo Nordisk har en øget risiko ved, at semaglutid ryger af patent i 2031 i USA.
Sådan ser jeg det ikke. Patentet er allerede delvist værdiløst, da der er tæt på nulvækst og "compounders" servicerer hele markedet i USA. En dyr lektie, men bunden er nået.
#dkøko
Sådan ser jeg det ikke. Patentet er allerede delvist værdiløst, da der er tæt på nulvækst og "compounders" servicerer hele markedet i USA. En dyr lektie, men bunden er nået.
#dkøko
A month after Eli Lilly first claimed that all of its tirzepatide was "available"
FDA says it still thinks that drug is "currently in shortage"
This allows compounders to keep making copies of Mounjaro for diabetes and Zepbound for weight loss
dps.fda.gov/drugshortage...
FDA says it still thinks that drug is "currently in shortage"
This allows compounders to keep making copies of Mounjaro for diabetes and Zepbound for weight loss
dps.fda.gov/drugshortage...
September 11, 2024 at 4:46 PM
A month after Eli Lilly first claimed that all of its tirzepatide was "available"
FDA says it still thinks that drug is "currently in shortage"
This allows compounders to keep making copies of Mounjaro for diabetes and Zepbound for weight loss
dps.fda.gov/drugshortage...
FDA says it still thinks that drug is "currently in shortage"
This allows compounders to keep making copies of Mounjaro for diabetes and Zepbound for weight loss
dps.fda.gov/drugshortage...
Grey market meaning bought from pharmacies and compounders in other countries who have set up exactly for this situation. It’s not a crime for me to buy it, just a crime for them to sell it. And only a crime in America, a country they are not in.
December 17, 2024 at 7:30 PM
Grey market meaning bought from pharmacies and compounders in other countries who have set up exactly for this situation. It’s not a crime for me to buy it, just a crime for them to sell it. And only a crime in America, a country they are not in.
depends where you get them, "legit" routes usually give you vials you can use for a few weeks or months in the US, but most DIY compounders sell single vials that will last you around 1-1.5 years depending on the ester
monotherapy is great and probably the best method of blocking, but if your
monotherapy is great and probably the best method of blocking, but if your
November 28, 2024 at 6:48 PM
depends where you get them, "legit" routes usually give you vials you can use for a few weeks or months in the US, but most DIY compounders sell single vials that will last you around 1-1.5 years depending on the ester
monotherapy is great and probably the best method of blocking, but if your
monotherapy is great and probably the best method of blocking, but if your
The new Scott Act Inspector Rogers is after the liquor dealers in grand style. Our genial compounders of the ardent had to dance to the tune of a $50 fine on Friday last, and the papers are out for another offence which will be tried in a few days. Hopewell Feb 16 1894
November 23, 2024 at 12:18 AM
The new Scott Act Inspector Rogers is after the liquor dealers in grand style. Our genial compounders of the ardent had to dance to the tune of a $50 fine on Friday last, and the papers are out for another offence which will be tried in a few days. Hopewell Feb 16 1894
And if you use alternatives like CTA and dynamic rebalancing by a limit orders during corrections then you are compounding your hyper compounders which mega compounds your income stocks!
March 27, 2025 at 2:37 PM
And if you use alternatives like CTA and dynamic rebalancing by a limit orders during corrections then you are compounding your hyper compounders which mega compounds your income stocks!
With compounders out of the way, Lilly and Novo go after each other via PharmaVoice www.pharmavoice.com/news/eli-lil...
With compounders out of the way, Lilly and Novo go after each other
The two obesity leaders are pulling on all levers to stay on top of the market.
www.pharmavoice.com
May 7, 2025 at 6:21 PM
With compounders out of the way, Lilly and Novo go after each other via PharmaVoice www.pharmavoice.com/news/eli-lil...
This whole thread is an example of a debate that just needs people to disagregate the data and focus on composition effects and compounders. E.g. at low incomes stress causes impulsive irrational desperation. At higher incomes, its loose money fuelling speculative behavior.
Whatever happens in this guy’s mind must be something truly special.
July 27, 2025 at 4:31 PM
This whole thread is an example of a debate that just needs people to disagregate the data and focus on composition effects and compounders. E.g. at low incomes stress causes impulsive irrational desperation. At higher incomes, its loose money fuelling speculative behavior.
Drug compounders sue over weight loss drugs' removal from FDA shortage list thehill.com/policy/healt...
thehill.com
February 27, 2025 at 3:02 AM
Drug compounders sue over weight loss drugs' removal from FDA shortage list thehill.com/policy/healt...
Make your 🇺🇸 system cover the expenses
Novo has lowered the price often and will keep doing so
🇺🇸law is currently letting compounders produce a “look a like” who isn’t tested and no one knows what’s in it. It’s taking up to 40% of the 🇺🇸market
Novo has high expenses for R&D & building new factories
Novo has lowered the price often and will keep doing so
🇺🇸law is currently letting compounders produce a “look a like” who isn’t tested and no one knows what’s in it. It’s taking up to 40% of the 🇺🇸market
Novo has high expenses for R&D & building new factories
March 28, 2025 at 5:54 PM
Make your 🇺🇸 system cover the expenses
Novo has lowered the price often and will keep doing so
🇺🇸law is currently letting compounders produce a “look a like” who isn’t tested and no one knows what’s in it. It’s taking up to 40% of the 🇺🇸market
Novo has high expenses for R&D & building new factories
Novo has lowered the price often and will keep doing so
🇺🇸law is currently letting compounders produce a “look a like” who isn’t tested and no one knows what’s in it. It’s taking up to 40% of the 🇺🇸market
Novo has high expenses for R&D & building new factories
Even $500 a month is steep. Wild that the compounders can sell it for $200 a month and still make a profit.
May 22, 2025 at 1:07 PM
Even $500 a month is steep. Wild that the compounders can sell it for $200 a month and still make a profit.
Compounders are sidestepping rules by tweaking formulas & dosages to keep selling cheaper Ozempic alternatives. Patients face frequent changes but stick with them for cost savings
May 27, 2025 at 3:38 PM
Compounders are sidestepping rules by tweaking formulas & dosages to keep selling cheaper Ozempic alternatives. Patients face frequent changes but stick with them for cost savings
Interesting read, and I'm rooting for the compounders.
I took compounded semaglutide a year ago and lost 40 pounds. That loss brought my blood pressure down to healthy levels.
I took compounded semaglutide a year ago and lost 40 pounds. That loss brought my blood pressure down to healthy levels.
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.
The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.
buff.ly
February 22, 2025 at 6:05 PM
Interesting read, and I'm rooting for the compounders.
I took compounded semaglutide a year ago and lost 40 pounds. That loss brought my blood pressure down to healthy levels.
I took compounded semaglutide a year ago and lost 40 pounds. That loss brought my blood pressure down to healthy levels.
The importance of mastering taxes! I have been working a lot on that aspect as it can make a massive difference. In France there are some things to be done and it is known for its complexity.
There are different favorable tax enveloppes. True also that holding long term compounders is nice too.
1/
There are different favorable tax enveloppes. True also that holding long term compounders is nice too.
1/
January 12, 2025 at 8:31 AM
The importance of mastering taxes! I have been working a lot on that aspect as it can make a massive difference. In France there are some things to be done and it is known for its complexity.
There are different favorable tax enveloppes. True also that holding long term compounders is nice too.
1/
There are different favorable tax enveloppes. True also that holding long term compounders is nice too.
1/
treats hair loss in men, more to come
11:02 FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products
11:02 FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products
April 22, 2025 at 3:50 PM
treats hair loss in men, more to come
11:02 FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products
11:02 FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period www.statnews.com/2024/12/19/f... via @statnews.com
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put a stop to companies making cheaper copies.
www.statnews.com
January 6, 2025 at 1:27 PM
FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period www.statnews.com/2024/12/19/f... via @statnews.com
$POOL : -46,5% 💦
➡️FCF Growth (CAGR 10 ans) : 19,5%
➡️ROIC : 18,6%
➡️Rendement annuel (10 ans) : 17,6%
Un des meilleurs "compounders" du $SPX entre 2000-2020. Malgré la croissance négative récente, le parc installé de piscines continue d'augmenter = revenus récurrents garantis.
➡️FCF Growth (CAGR 10 ans) : 19,5%
➡️ROIC : 18,6%
➡️Rendement annuel (10 ans) : 17,6%
Un des meilleurs "compounders" du $SPX entre 2000-2020. Malgré la croissance négative récente, le parc installé de piscines continue d'augmenter = revenus récurrents garantis.
May 19, 2025 at 5:47 PM
$POOL : -46,5% 💦
➡️FCF Growth (CAGR 10 ans) : 19,5%
➡️ROIC : 18,6%
➡️Rendement annuel (10 ans) : 17,6%
Un des meilleurs "compounders" du $SPX entre 2000-2020. Malgré la croissance négative récente, le parc installé de piscines continue d'augmenter = revenus récurrents garantis.
➡️FCF Growth (CAGR 10 ans) : 19,5%
➡️ROIC : 18,6%
➡️Rendement annuel (10 ans) : 17,6%
Un des meilleurs "compounders" du $SPX entre 2000-2020. Malgré la croissance négative récente, le parc installé de piscines continue d'augmenter = revenus récurrents garantis.
Compounders, återinvesterare eller serieförvärvare – kärt barn har många namn. Bolagen har gått urstarkt på börsen, men vad kännetecknar dem? Och vilka blir nästa vinnare?
efn.se/play/borslun...
efn.se/play/borslun...
Framgångsreceptet bakom 100-dubblarna
Framgångsreceptet bakom 100-dubblarna| Håll dig uppdaterad med aktuella ekonominyheter – gratis.
efn.se
September 23, 2025 at 10:40 AM
Compounders, återinvesterare eller serieförvärvare – kärt barn har många namn. Bolagen har gått urstarkt på börsen, men vad kännetecknar dem? Och vilka blir nästa vinnare?
efn.se/play/borslun...
efn.se/play/borslun...